A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells.
Inoue A, Mizushima T, Wu X, Okuzaki D, Kambara N, Ishikawa S, Wang J, Qian Y, Hirose H, Yokoyama Y, Ikeshima R, Hiraki M, Miyoshi N, Takahashi H, Haraguchi N, Hata T, Matsuda C, Doki Y, Mori M, Yamamoto H.
Inoue A, et al. Among authors: hiraki m.
Mol Cancer Ther. 2018 May;17(5):977-987. doi: 10.1158/1535-7163.MCT-17-0850. Epub 2018 Mar 15.
Mol Cancer Ther. 2018.
PMID: 29545333